prolinedithiocarbamate has been researched along with Cancer of Prostate in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Di, JM; Fang, YQ; Gao, X; Liu, XP; Pang, J; Pu, XY; Ruan, XX; Zhang, Y | 1 |
Gunawardena, K; Meikle, AW; Murray, DK; Swope, RE | 1 |
Campbell, LD; Gunawardena, K; Meikle, AW | 1 |
Beham, AW; Brisbay, S; Bruckheimer, EM; Chiao, PJ; Herrmann, JL; McDonnell, TJ; Rands, MT; Sarkiss, M | 1 |
Gunawardena, K; Meikle, AW; Murray, DK | 2 |
6 other study(ies) available for prolinedithiocarbamate and Cancer of Prostate
Article | Year |
---|---|
Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells.
Topics: Cell Line, Tumor; Cell Nucleus; Chloroquine; Humans; Interleukin-8; Male; NF-kappa B; Oligodeoxyribonucleotides; Proline; Prostatic Neoplasms; Protein Transport; Signal Transduction; Thiocarbamates; Toll-Like Receptor 9; Transforming Growth Factor beta1 | 2009 |
Inhibition of nuclear factor kappaB induces apoptosis following treatment with tumor necrosis factor alpha and an antioxidant in human prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Computer Graphics; Humans; Male; Neoplasm Proteins; NF-kappa B; Proline; Prostatic Neoplasms; Protein Biosynthesis; Proteins; Thiocarbamates; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Antiandrogen-like actions of an antioxidant on survivin, Bcl-2 and PSA in human prostate cancer cells.
Topics: Androgen Antagonists; Antineoplastic Agents; Antioxidants; Apoptosis; Blotting, Northern; Blotting, Western; Cell Growth Processes; Cell Survival; Electrophoretic Mobility Shift Assay; Humans; Inhibitor of Apoptosis Proteins; Male; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasms, Hormone-Dependent; NF-kappa B; Proline; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survivin; Testosterone; Thiocarbamates; Tumor Cells, Cultured | 2005 |
Bcl-2 suppresses apoptosis resulting from disruption of the NF-kappa B survival pathway.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Cell Survival; DNA-Binding Proteins; Humans; I-kappa B Proteins; Kinetics; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Proline; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; Recombinant Proteins; Signal Transduction; Thiocarbamates; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1997 |
Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis.
Topics: Androgens; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Division; Ditiocarb; Drug Interactions; Epithelial Cells; Growth Inhibitors; Humans; Male; Necrosis; Neoplasms, Hormone-Dependent; Proline; Prostatic Neoplasms; Testosterone; Thiocarbamates; Tumor Cells, Cultured; Vitamin E | 2000 |
Testosterone is a potential augmentor of antioxidant-induced apoptosis in human prostate cancer cells.
Topics: Androgens; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Division; Cell Nucleus; Electrophoretic Mobility Shift Assay; Epithelial Cells; Humans; Male; Neoplasms, Hormone-Dependent; NF-kappa B; Proline; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Testosterone; Thiocarbamates; Tumor Cells, Cultured; Up-Regulation | 2002 |